39th week of 2019 patent applcation highlights part 25 |
Patent application number | Title | Published |
20190292177 | AN IMPROVED PROCESS FOR THE PREPARATION OF DASATINIB POLYMORPH | 2019-09-26 |
20190292178 | HOST TARGETED INHIBITORS OF DENGUE VIRUS AND OTHER VIRUSES | 2019-09-26 |
20190292179 | TGF Beta RECEPTOR ANTAGONISTS | 2019-09-26 |
20190292180 | ALDOSTERONE SYNTHASE INHIBITOR | 2019-09-26 |
20190292181 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | 2019-09-26 |
20190292182 | QUINAZOLINE COMPOUND | 2019-09-26 |
20190292183 | PYRIMIDO[5,4-B]INDOLIZINE OR PYRIMIDO[5,4-B]PYRROLIZINE COMPOUND, PREPARATION METHOD AND USE THEREOF | 2019-09-26 |
20190292184 | NOVEL PYRIDO-PHENANTHROLINE DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAMENTS | 2019-09-26 |
20190292185 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | 2019-09-26 |
20190292186 | XANTHINE DERIVATIVE INHIBITORS OF BET PROTEINS | 2019-09-26 |
20190292187 | SUBSTITUTED PYRROLIZINE COMPOUNDS AND USES THEREOF | 2019-09-26 |
20190292188 | IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS | 2019-09-26 |
20190292189 | LIM KINASE INHIBITORS | 2019-09-26 |
20190292190 | NOVEL 5H-PYRROLO[2,3-D]PYRIMIDIN-6(7H)-ONE DERIVATIVE | 2019-09-26 |
20190292191 | HETEROARYL SUBSTITUTED AMINOPYRIDINE COMPOUNDS | 2019-09-26 |
20190292192 | METHANESULFONATE POLYMORPH OF 5-TYPE PHOSPHODIESTERASE INHIBITOR AND PREPARATION METHOD AND APPLICATIONS THEREOF | 2019-09-26 |
20190292193 | SOLID FORMS OF TTK INHIBITOR | 2019-09-26 |
20190292194 | INHIBITORS OF ERK AND METHODS OF USE | 2019-09-26 |
20190292195 | 2-AMINOQUINAZOLINE DERIVATIVES AS P70S6 KINASE INHIBITORS | 2019-09-26 |
20190292196 | MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED THERETO | 2019-09-26 |
20190292197 | Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses | 2019-09-26 |
20190292198 | A NEW CRYSTAL SALT FORM OF 2,2-DIMETHYL-6-((4-((3,4,5-TRIMETHOXYPHENYL)AMINO)-1,3,5-TRIAZINE-2-YL)AM- INO)-2H PYRIDO[3,2-B][1,4]OXAZINE-3(4H)-ONE FOR HUMAN USE | 2019-09-26 |
20190292199 | HETEROCYCLIC COMPOUNDS USEFUL AS ANTI-BACTERIAL AGENTS AND METHOD FOR PRODUCTION | 2019-09-26 |
20190292200 | METHOD FOR PREPARING 2-(CYCLOHEXENYLIDENE) MALONIC ACID DERIVATIVES AND USES THEREOF | 2019-09-26 |
20190292201 | PROCESS FOR THE PREPARATION OF (S)-2-((2-((S)-4-(DIFLUOROMETHYL)-2-OXOOXAZOLIDIN-3-YL)-5,6-DIHYDROBENZO[- F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)AMINO) PROP AN AMIDE | 2019-09-26 |
20190292202 | NOVEL HETEROCYCLIC SYSTEMS AND PHARMACEUTICAL APPLICATIONS THEREOF | 2019-09-26 |
20190292203 | HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS | 2019-09-26 |
20190292204 | NOVEL HETEROCYCLIC SYSTEMS AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2019-09-26 |
20190292205 | Novel 2,3-Dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one Derivatives Comprising a Substituted Morpholine, Preparation Thereof and Pharmaceutical Use Thereof | 2019-09-26 |
20190292206 | GADOLINIUM COMPLEX, METHOD FOR SYNTHESIS OF THE GADOLINIUM COMPLEX, AND MRI CONTRAST AGENT INCLUDING THE GADOLINIUM COMPLEX | 2019-09-26 |
20190292207 | METHOD OF FORMING A THIN FILM | 2019-09-26 |
20190292208 | PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS | 2019-09-26 |
20190292209 | NOVEL COMPOUNDS AND PROCESS FOR PREPARATION OF THE SAME FROM CASHEW NUT SHELL LIQUID (CNSL) | 2019-09-26 |
20190292210 | BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES | 2019-09-26 |
20190292211 | PROCESS FOR PURIFICATION OF NEUTRAL HUMAN MILK OLIGOSACCHARIDE USING SIMULATED MOVING BED CHROMATOGRAPHY | 2019-09-26 |
20190292213 | 5`S-LNA nucleotides and oligonucleotides | 2019-09-26 |
20190292214 | NEW EQUATORIALLY MODIFIED POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES | 2019-09-26 |
20190292215 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | 2019-09-26 |
20190292216 | Cyclic Di-Nucleotide Induction of Type I Interferon | 2019-09-26 |
20190292217 | TRANSGENIC PLANTS WITH UPREGULATED HEME BIOSYNTHESIS | 2019-09-26 |
20190292218 | THIOL-YNE BASED PEPTIDE STAPLING AND USES THEREOF | 2019-09-26 |
20190292219 | METHOD OF SOLID-STATE PEPTIDE SYNTHESIS USING A NOVEL POLYMERIC SUPPORT | 2019-09-26 |
20190292220 | MULTIDIMENSIONAL CHROMATOGRAPHY METHOD FOR ANALYSIS OF ANTIBODY-DRUG CONJUGATES | 2019-09-26 |
20190292221 | METHODS OF INACTIVATING VIRAL CONTAMINANTS | 2019-09-26 |
20190292222 | NON-ANTIBODY HIGH-AFFINITY-BASED SAMPLE PREPARATION, SORBENT, DEVICES AND METHODS | 2019-09-26 |
20190292223 | SAP AND PEPTIDOMIMETICS FOR TREATMENT OF EYE DISEASE | 2019-09-26 |
20190292224 | TRIAZOLE-CROSSLINKED AND THIOETHER-CROSSLINKED PEPTIDOMIMETIC MACROCYCLES | 2019-09-26 |
20190292225 | AUREOBASIDIUM DERIVATIVES AND METHODS OF SYNTHESIS | 2019-09-26 |
20190292226 | SAP AND PEPTIDOMIMETIC COMPOSITIONS FOR REDUCING SYMPTOMS OF INFLAMMATION | 2019-09-26 |
20190292227 | CONFORMATIONALLY-PREORGANIZED, MINIPEG-CONTAINING GAMMA-PEPTIDE NUCLEIC ACIDS | 2019-09-26 |
20190292228 | CONFORMATIONALLY STABILIZED RSV PRE-FUSION F PROTEINS | 2019-09-26 |
20190292229 | METHOD FOR PRODUCING SELF-ASSEMBLING PARAMYXOVIRAL NUCLEOCAPSID-LIKE PARTICLES AND THEIR USES | 2019-09-26 |
20190292230 | SELECTIVE RECOVERY | 2019-09-26 |
20190292231 | RECOMBINANT PROTEINS OF PARAPOXVIRUS OVIS AND PHARMACEUTICAL COMPOSITIONS THEREFROM | 2019-09-26 |
20190292232 | Gluten-Derived Flame Retardant Materials | 2019-09-26 |
20190292233 | ANTIMICROBIAL PEPTIDES | 2019-09-26 |
20190292234 | ANTIMICROBIAL PEPTIDES | 2019-09-26 |
20190292235 | Biological Nanopores for Biopolymer Sensing and Sequencing Based on FRAC Actinoporin | 2019-09-26 |
20190292236 | MODULATION OF IFI16 AND STING ACTIVITY | 2019-09-26 |
20190292237 | COMPOSITIONS COMPRISING A P75 TUMOR NECROSIS FACTOR RECEPTOR/IG FUSION PROTEIN | 2019-09-26 |
20190292238 | CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR)- EXPRESSING CELL | 2019-09-26 |
20190292239 | VEGF-BINDING PROTEIN FOR BLOCKADE OF ANGIOGENESIS | 2019-09-26 |
20190292240 | CELL EXPRESSING CAR AND GPCR | 2019-09-26 |
20190292241 | GDF15 FUSION PROTEINS AND USES THEREOF | 2019-09-26 |
20190292242 | Hydrolyzed Jellyfish Collagen Types I, II, and V and Use Thereof | 2019-09-26 |
20190292243 | PEPTIDES AND METHODS OF USE THEREOF | 2019-09-26 |
20190292244 | COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF IRON-RELATED DISORDERS | 2019-09-26 |
20190292245 | HUMANIZED ANTI-TAU ANTIBODIES AND COMPOSITIONS FOR AND METHODS OF MAKING AND USING IN TREATMENT, DIAGNOSIS AND MONITORING OF TAUOPATHIES | 2019-09-26 |
20190292246 | COMBINATION THERAPY OF A CELL BASED THERAPY AND A MICROGLIA IMHIBITOR | 2019-09-26 |
20190292247 | NOVEL AMYLOID BETA OLIGOMER SPECIFIC BINDING MOLECULE | 2019-09-26 |
20190292248 | ANTI-ALPHA-SYNUCLEIN ANTIBODIES AND METHODS OF USE | 2019-09-26 |
20190292249 | ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THAT SPECIFICALLY BIND TO MICROTUBULE-ASSOCIATED PROTEIN TAU | 2019-09-26 |
20190292250 | AAV-ANTI-VEGF FOR TREATING CANCER IN COMPANION ANIMALS | 2019-09-26 |
20190292251 | TREATMENT OF CONGESTIVE HEART FAILURE AND OTHER CARDIAC DYSFUNCTION USING A GDF15 MODULATOR | 2019-09-26 |
20190292252 | TREATMENT OF CHRONIC KIDNEY DISEASE AND OTHER RENAL DYSFUNCTION USING A GDF15 MODULATOR | 2019-09-26 |
20190292253 | METHODS OF REVERSING CACHEXIA AND PROLONGING SURVIVAL COMPRISING ADMINISTERING A GDF15 MODULATOR AND AN ANTI-CANCER AGENT | 2019-09-26 |
20190292254 | TGFBeta Antibodies, Methods and Uses | 2019-09-26 |
20190292255 | Methods of Treatment Using Anti-IL-17A/F Antibodies | 2019-09-26 |
20190292256 | Compounds and Methods to Measure Metabolic Function and Restore Normal Metabolic Function | 2019-09-26 |
20190292257 | METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR - EXPRESSING CELLS | 2019-09-26 |
20190292258 | ANTI-CD47 ANTIBODIES | 2019-09-26 |
20190292259 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NON SMALL CELL LUNG CANCER (NSCLC) THAT COEXISTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) | 2019-09-26 |
20190292260 | ANTI-PD-1 ANTIBODY FOR USE IN A METHOD OF TREATMENT OF RECURRENT SMALL CELL LUNG CANCER | 2019-09-26 |
20190292261 | Anti-PD-1 Antibodies | 2019-09-26 |
20190292262 | LOW DOSE IMMUNE CHECKPOINT BLOCKADE IN METASTATIC CANCER | 2019-09-26 |
20190292263 | GENETICALLY MODIFIED NON-HUMAN ANIMALS FOR GENERATING THERAPEUTIC ANTIBODIES AGAINST PEPTIDE-MHC COMPLEXES, METHODS OF MAKING AND USES THEREOF | 2019-09-26 |
20190292264 | KLRG1 SIGNALING THERAPY | 2019-09-26 |
20190292265 | Methods of Treating Crohn's Disease with an Anti-NKG2D Antibody | 2019-09-26 |
20190292266 | NOVEL BINDING PROTEINS COMPRISING A UBIQUITIN MUTEIN AND ANTIBODIES OR ANTIBODY FRAGMENTS | 2019-09-26 |
20190292267 | BISPECIFIC CXCR4-CD4 POLYPEPTIDES WITH POTENT ANTI-HIV ACTIVITY | 2019-09-26 |
20190292268 | Methods for Producing Fabs and IgG Bispecific Antibodies | 2019-09-26 |
20190292269 | FC POLYPEPTIDE VARIANTS HAVING AN INCREASED HALF-LIFE | 2019-09-26 |
20190292270 | Anti-TLR9 Antibody, Pharmaceutical Composition, and Kit | 2019-09-26 |
20190292271 | ANTIBODIES AGAINST THE ECTODOMAIN OF ERBB3 AND USES THEREOF | 2019-09-26 |
20190292272 | Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation | 2019-09-26 |
20190292273 | METHODS FOR REDUCING CARDIOVASCULAR RISK | 2019-09-26 |
20190292274 | BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF | 2019-09-26 |
20190292275 | SEQUENCING-DIRECTED SELECTION OF TUMOR THERANOSTICS | 2019-09-26 |
20190292276 | INTERNALIZING MOIETIES | 2019-09-26 |
20190292277 | NANOCELLULOSE COMPOSITIONS AND PROCESSES TO PRODUCE SAME | 2019-09-26 |